Pulmonary Disease Doctors in Derby, CT Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Bassam Tahir Choudhry, M.D, M.P.H Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7327

Kenneth J Dobuler, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7573    Fax: 203-732-7418

Kathleen M Chaisson, M.D. Internal Medicine - Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 130 Division St, Derby, CT 06418 Phone: 203-732-7573    Fax: 203-732-7418

News Archive

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin.

Discovery of five genetic variants related to blood pressure in African-Americans

A team led by researchers from the National Institutes of Health (NIH) has reported the discovery of five genetic variants related to blood pressure in African-Americans, findings that may provide new clues to treating and preventing hypertension. The effort marks the first time that a relatively new research approach, called a genome-wide association study, has focused on blood pressure and hypertension in an African-American population.

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics," in Berlin, Germany.

Researchers discover new cause to explain development of temporal lobe epilepsy

Epilepsy is a very prevalent neurological disorder. Approximately one-third of patients are resistant to currently available therapies. A team of researchers under the guidance of the Institute of Cellular Neurosciences at the University of Bonn has discovered a new cause to explain the development of temporal lobe epilepsy: At an early stage, astrocytes are uncoupled from each other.

Read more Medical News

› Verified 5 days ago